Cesca van de Ven

694 total citations
16 papers, 474 citations indexed

About

Cesca van de Ven is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, Cesca van de Ven has authored 16 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 9 papers in Hematology and 6 papers in Genetics. Recurrent topics in Cesca van de Ven's work include Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Cesca van de Ven is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Cesca van de Ven collaborates with scholars based in Netherlands, Germany and United Kingdom. Cesca van de Ven's co-authors include Jacqueline Deschamps, Felix Beck, Monika Bialecka, Jennifer Rowland, Jean‐Noël Freund, Ana Nóvoa, Moisés Mallo, Teddy Young, Isabelle Duluc and Wim de Graaff and has published in prestigious journals such as Blood, Development and Nature Protocols.

In The Last Decade

Cesca van de Ven

16 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cesca van de Ven Netherlands 8 319 117 107 96 49 16 474
Elizabeth J. Heller United States 6 541 1.7× 222 1.9× 83 0.8× 147 1.5× 55 1.1× 6 856
Giulia Arrigo Italy 12 339 1.1× 121 1.0× 240 2.2× 27 0.3× 48 1.0× 21 594
Emilie Falconnet Switzerland 15 409 1.3× 88 0.8× 251 2.3× 67 0.7× 91 1.9× 16 672
Jonathan R. Yeh Canada 10 282 0.9× 241 2.1× 190 1.8× 65 0.7× 23 0.5× 14 531
Pauline Parry United States 7 265 0.8× 73 0.6× 90 0.8× 131 1.4× 20 0.4× 8 432
Liselotte Vesterlund Sweden 11 339 1.1× 43 0.4× 106 1.0× 35 0.4× 35 0.7× 14 493
Trisha A. Macrae United States 6 435 1.4× 42 0.4× 52 0.5× 94 1.0× 15 0.3× 8 537
Vasilios Zachariadis Sweden 11 157 0.5× 113 1.0× 90 0.8× 100 1.0× 59 1.2× 20 392
Philippe Coullin France 15 268 0.8× 132 1.1× 208 1.9× 22 0.2× 189 3.9× 28 526
Vida Petrovic Australia 10 390 1.2× 39 0.3× 301 2.8× 40 0.4× 64 1.3× 19 600

Countries citing papers authored by Cesca van de Ven

Since Specialization
Citations

This map shows the geographic impact of Cesca van de Ven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cesca van de Ven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cesca van de Ven more than expected).

Fields of papers citing papers by Cesca van de Ven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cesca van de Ven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cesca van de Ven. The network helps show where Cesca van de Ven may publish in the future.

Co-authorship network of co-authors of Cesca van de Ven

This figure shows the co-authorship network connecting the top 25 collaborators of Cesca van de Ven. A scholar is included among the top collaborators of Cesca van de Ven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cesca van de Ven. Cesca van de Ven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Boeree, Aurélie, et al.. (2025). Secondary lesions and sensitivity to signaling inhibitors in iAMP21 acute lymphoblastic leukemia. HemaSphere. 9(1). e70069–e70069. 2 indexed citations
2.
Alieva, María, Sam de Blank, Amber L. Zeeman, et al.. (2024). BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response. Nature Protocols. 19(7). 2052–2084. 9 indexed citations
3.
Boer, Judith M., Cesca van de Ven, Aurélie Boeree, et al.. (2024). Tyrosine kinase inhibitor resistance in de novo BCR::ABL1–positive BCP-ALL beyond kinase domain mutations. Blood Advances. 8(8). 1835–1845. 1 indexed citations
4.
Steeghs, Elisabeth M. P., et al.. (2024). B-cell precursor acute lymphoblastic leukemia elicits an interferon-α/βresponse in bone marrow-derived mesenchymal stroma. Haematologica. 109(7). 2073–2084. 1 indexed citations
5.
Boeree, Aurélie, Cesca van de Ven, Gabriele Escherich, et al.. (2023). Secondary Lesions and Sensitivity to Signaling Inhibitors of Pediatric iAMP21 B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 142(Supplement 1). 1613–1613. 1 indexed citations
6.
Boeree, Aurélie, Cesca van de Ven, Hester A. de Groot‐Kruseman, et al.. (2023). Novel Insights in TKI Resistance in BCR:: ABL1-Positive B-Cell Acute Lymphoblastic Leukemia Beyond Kinase Domain Mutations. Blood. 142(Supplement 1). 1615–1615. 1 indexed citations
7.
Ven, Cesca van de, et al.. (2020). Ibrutinib is not an effective drug in primografts of TCF3-PBX1. Translational Oncology. 13(10). 100817–100817. 2 indexed citations
8.
9.
Steeghs, Elisabeth M. P., Isabel S. Jerchel, Judith M. Boer, et al.. (2017). JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia. Oncotarget. 8(52). 89923–89938. 37 indexed citations
10.
Jerchel, Isabel S., Ingrid M. Ariës, Elisabeth M. P. Steeghs, et al.. (2017). RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia. Leukemia. 32(4). 931–940. 74 indexed citations
11.
Steeghs, Elisabeth M. P., Isabel S. Jerchel, Judith M. Boer, et al.. (2016). JAK2 Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 128(22). 583–583. 13 indexed citations
12.
Jerchel, Isabel S., Ingrid M. Ariës, Elisabeth M. P. Steeghs, et al.. (2016). RAS Pathway Mutations As Predictive Biomarker for Treatment Adaptation in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Blood. 128(22). 4087–4087. 14 indexed citations
13.
Rooijen, Carina van, Salvatore Simmini, Monika Bialecka, et al.. (2012). Evolutionarily conserved requirement of Cdx for post-occipital tissue emergence. Development. 139(14). 2576–2583. 50 indexed citations
14.
Ven, Cesca van de, Monika Bialecka, Roel Neijts, et al.. (2011). Concerted involvement of Cdx/Hox genes and Wnt signaling in morphogenesis of the caudal neural tube and cloacal derivatives from the posterior growth zone. Development. 138(16). 3451–3462. 63 indexed citations
15.
Ven, Cesca van de, Monika Białecka, Roel Neijts, et al.. (2011). Concerted involvement of Cdx/Hox genes and Wnt signaling in morphogenesis of the caudal neural tube and cloacal derivatives from the posterior growth zone. Development. 138(17). 3859–3859. 7 indexed citations
16.
Young, Teddy, Jennifer Rowland, Cesca van de Ven, et al.. (2009). Cdx and Hox Genes Differentially Regulate Posterior Axial Growth in Mammalian Embryos. Developmental Cell. 17(4). 516–526. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth J. Heller Breakdown of academic impact, for papers by Giulia Arrigo Breakdown of academic impact, for papers by Emilie Falconnet Breakdown of academic impact, for papers by Jonathan R. Yeh Breakdown of academic impact, for papers by Pauline Parry Breakdown of academic impact, for papers by Liselotte Vesterlund Breakdown of academic impact, for papers by Trisha A. Macrae Breakdown of academic impact, for papers by Vasilios Zachariadis Breakdown of academic impact, for papers by Philippe Coullin Breakdown of academic impact, for papers by Vida Petrovic
Rankless by CCL
2026